CareDx CDNA shares soared 7% in the last trading session to close at $12.75. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the ...
Assessing comparative efficacies of camrelizumab as a single or combination therapy in patients with hepatocellular carcinoma: A systematic review and network meta-analysis. This is an ASCO Meeting ...
RNLs (RPW8-NLRs) are a phylogenetically distinct class of nucleotide oligomerization domain (NOD)-like receptors (NLRs) identified in plants. Two RNLs, namely, the NRG1 (N Requirement Gene 1) and the ...
In addition to the Instinct MI325X AI Accelerator, AMD also updated its AMD Instinct roadmap and previewed the upcoming Instinct MI355X AI Accelerator at its Advance AI event held earlier. Based on ...
I reiterate a “Buy” rating for Advanced Micro Devices with a fair value of $205 per share, driven by strong R&D and growth prospects. AMD's upcoming Instinct MI325X and future MI350 and MI400 series, ...
This valuable manuscript reports alterations in autophagy present in dopaminergic neurons differentiated from iPSCs in patients with WDR45 mutations. The authors identified compounds that improved the ...
Global food and nutritional security are being threatened by abiotic stresses such as drought, salinity, cold, and heat, owing to the rapid and deleterious effects of climate change. Millets represent ...
AMD’s new UDNA strategy is all about AI, and it’s hard to blame the company. AMD’s new UDNA strategy is all about AI, and it’s hard to blame the company. is a senior editor and founding member of The ...
Ever since it bought GPU firm ATI Technologies in 2006, AMD has experimented with all kinds of graphics architectures. Its current approach, one for PC clients and the other for data and AI servers, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback